The global gene therapy market was valued at USD 3.61 billion in 2019 and is projected to reach USD 35.67 billion by 2027, growing at a robust compound annual growth rate (CAGR) of 33.6%. In 2019, the United States led the global landscape, accounting for 59.83% of the total market share.

The gene therapy market is emerging as a transformative force in modern medicine, offering the potential to treat or even cure a wide range of genetic and chronic diseases. By targeting the underlying genetic causes of disorders, gene therapy provides a more precise and long-lasting therapeutic approach compared to traditional treatments. The market is being driven by advancements in gene editing technologies, increasing R&D investments, and a growing number of regulatory approvals for novel therapies. With expanding applications in oncology, rare genetic conditions, and neurology, the gene therapy market is gaining significant traction. Despite challenges such as high costs, regulatory complexity, and manufacturing hurdles, the future of the gene therapy market appears promising, fueled by ongoing innovation and global healthcare demand.

Continue reading for more details:

**https://www.fortunebusinessinsights.com/industry-reports/gene-therapy-market-100243**

Market Segmentation

• The gene therapy market is segmented by therapy type, including somatic gene therapy and germline gene therapy.
• By vector type, the market includes viral vectors (lentivirus, adeno-associated virus, retrovirus) and non-viral vectors (naked DNA, liposomes).
• Based on indication, the gene therapy market covers oncology, genetic disorders, cardiovascular diseases, neurological disorders, and infectious diseases.
• By delivery method, the market is segmented into in vivo and ex vivo gene therapies.
• The gene therapy market also segments by end-users, including hospitals, specialty clinics, and academic & research institutes.

List Of Key Companies Profiled in Gene Therapy Market:

• Novartis AG
• Spark Therapeutics, Inc.
• Biogen
• Gilead Sciences, Inc
• Amgen, Inc.
• Jazz Pharmaceuticals, Inc.
• Sarepta Therapeutics